Cooperative Agreement W81XWH0820047

This $2.9 million Defense Health Agency project grant funds research on suicide prevention among military personnel and veterans. The grant supports a multi-site randomized clinical trial through September 2026 to evaluate the efficacy of Written Exposure Therapy for Suicide Prevention compared to treatment as usual. Researchers at Boston University and partner institutions University of Colorado Denver and University of Texas Health Science Center San Antonio aim to reduce suicidal thoughts and...

This $2,763,615 federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports a randomized controlled trial of brief prolonged exposure therapy for injured individuals admitted to a Level I trauma center. The goal is to evaluate the effectiveness of this approach in preventing post-traumatic stress disorder (PTSD) in this patient population. The 4-year study is being conducted by the Baylor Research Institute, a non-profit...

This Project Grant award of $2,384,097, provided by the Defense Health Agency through the Military Medical Research and Development (CFDA 12.420) federal grant program, is funding a hybrid experimental clinical trial to determine the optimal sequencing of interventions to maximize the effectiveness of PTSD treatment. The primary awardee, The University of Texas Health Science Center at San Antonio, will conduct this research with a planned completion date of August 2028. The project involves two...

This federal Project Grant award of $2,993,024.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports a randomized controlled trial of lethal means safety counseling for service members and civilians with post-traumatic stress disorder (PTSD). The study, titled "FIREARM SAFETY IN PTSD (FASP): A RANDOMIZED CONTROLLED TRIAL OF LETHAL MEANS SAFETY COUNSELING AMONG SERVICE MEMBERS AND CIVILIANS WITH PTSD", will be conducted by...

The Defense Health Agency awarded a four-year, $936,532 Cooperative Agreement to the University of Texas Health Science Center at San Antonio (UTHSCSA) to implement and evaluate a patient-centered PTSD treatment program for military personnel. This award is funded under the Military Medical Research and Development (CFDA 12.420) program, which supports biomedical research to transform healthcare for service members and the public. Through this Cooperative Agreement, UTHSCSA will conduct research...

This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $6,964,861.00 to The University of Texas Health Science Center at San Antonio to conduct a multi-year longitudinal study focused on military psychological health. The study has five specific aims: Conduct a prospective, longitudinal follow-up of 3,360 previous clinical trial participants treated for PTSD, sleep disorders, or chronic pain. Conduct a...

The University of Texas Health Science Center of San Antonio will receive $3 million in cooperative agreement funding from the Department of the Army Medical Command to conduct a randomized clinical trial combining stellate ganglion block with prolonged exposure therapy for post-traumatic stress disorder (PTSD). The four-year award under the Military Medical Research and Development program (CFDA 12.420) aims to investigate medical solutions for traumatic battlefield injuries and transform...

This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop and evaluate an adapted version of Written Exposure Therapy (WET) for treating posttraumatic stress disorder (PTSD) among individuals with opioid use disorder (OUD) in residential substance use disorder (SUD) treatment settings. The $798,605 award will fund a multi-site study to create and test the adapted "Written Exposure in...

The Department of the Army Medical Command awarded a $7.286 million cooperative agreement to New York University School of Medicine to advance precision psychiatry for military service-related post-traumatic stress disorder (PTSD) by enhancing knowledge of clinical subtypes and their endophenotypes. Funded under the Military Medical Research and Development program (CFDA 12.420), this four-year cooperative agreement aims to transform military and public health care through innovative...

The Defense Health Agency has awarded a $1.632 million Project Grant to the Ocean State Research Institute, Inc., a non-profit research organization, to investigate the long-term outcomes of antipsychotic medication use in U.S. veterans with post-traumatic stress disorder (PTSD). This grant, funded through the Military Medical Research and Development program (CFDA 12.420), supports basic, applied, and advanced biomedical research to transform healthcare for service members and the public. As...